Contents
Hospice TPE medical review pairs a Medicare contractor’s examination of claims with education about billing problems. For an insider, the revealing part can be what happens after a reviewer asks for the chart. Did the hospice address the clinical finding, change the record, or keep billing for the same patient? The review file can connect what staff knew about the care to what management chose to claim.
Medicare Administrative Contractors process and pay claims, conduct medical reviews and work with healthcare providers on billing problems. Targeted Probe and Educate pairs review with provider education.
An additional documentation request, often called an ADR, asks the provider for medical records supporting a claim. The Congressional Research Service’s 2011 account of Medicare program integrity describes contractors using claim checks to identify billing problems, requesting records and conducting manual review before or after payment. It also describes contractors working directly with providers to correct mistakes found through review.
For someone examining possible hospice fraud, the useful connection reaches beyond the result letter. The chart shows the patient’s condition. The claim shows what Medicare was asked to pay. Internal instructions and audit findings can show who knew those accounts did not agree. A reviewer sees the response the hospice sends; an employee may know what was left out of it.
A hospice claim depends on the patient’s eligibility and the care being billed. Eligibility and recertification turn on a physician’s judgment that life expectancy is six months or less if the illness runs its normal course. The certification needs a patient-specific explanation of that judgment.
The physician narrative must reflect the individual’s clinical circumstances. Standard language used for every patient and check boxes cannot replace it. From the third benefit period onward, the narrative must explain why the face-to-face findings support the terminal prognosis. The useful comparison is between the examination, the clinical notes and the explanation the physician signed.
The election and the certification also do different jobs. An election can continue across benefit periods, while each period requires a fresh written certification. A patient remaining on the census therefore generates another clinical decision to examine. The Medicare hospice coverage manual describes the coverage and certification requirements behind those payments.
The billed level of hospice care adds another question. General inpatient care covers pain or symptom management that cannot be managed in another setting. Continuous home care addresses a crisis that allows the patient to remain at home. The care plan, clinical assessments and visit notes help connect what the patient needed with what the hospice supplied and billed.
Prepayment review examines a claim before Medicare pays it. Postpayment review examines claims Medicare has already paid and can identify money to recover. The timing changes the financial question: whether to pay the claim, or whether the hospice should return a payment.
The Congressional Research Service described both forms of manual medical review, including requests for additional documentation. It treated medical review, provider education and investigation as distinct functions. Contractors can refer suspected fraud for further investigation by the HHS Office of Inspector General and the Department of Justice.
A denial reason identifies the payment problem the reviewer found. An overpayment determination addresses money already paid. A fraud investigation examines suspected conduct behind the billing. The response to a review can become evidence in that investigation, especially where an employee saw an instruction to conceal records or invent clinical support.
OIG’s separate review of hospices’ compliance with Medicare requirements examines medical records and billing documentation to determine whether Medicare payments met the program’s requirements.
Quality surveys ask about care and the requirements for participating in Medicare. In Hospice Deficiencies Pose Risks to Medicare Beneficiaries, HHS OIG’s 2019 report, surveyors reviewed records, visited patients and investigated complaints. The report found recurring problems with care planning, aide services and assessments. For a clinical employee, those findings can describe the care failure that sits behind a billing concern.
The provisional period of enhanced oversight, known as PPEO, subjects specified hospices to medical review that can include prepayment review. Its scope follows enrollment and ownership circumstances as well as geography.
CMS began the program in 2023 in Arizona, California, Nevada and Texas. It covers newly enrolled hospices, specified ownership changes and hospices reactivating after deactivation. CMS’s February 2026 enhanced-oversight fact sheet describes the program and its expansion.
Expanded prepayment review reached existing providers in 2024 in the same states. Georgia and Ohio joined both initiatives in late 2025, as recorded in CMS’s hospice medical-review chronology.
CMS said it had received numerous reports of hospice fraud, waste and abuse and had concerns about rapid enrollment growth and market oversaturation. In its January 2026 Hospice Fast Facts, the agency reported that, through December 2025, it had medically reviewed 817 hospices under enhanced oversight and revoked the Medicare enrollment of 181 of them.
Long hospice stays can be more profitable because the daily payments continue through a period when the hospice supplies fewer services. MedPAC’s March 2026 report explains that services tend to be concentrated at the beginning and end of a hospice episode, with fewer in the middle.
HHS OIG put the incentive plainly in its 2015 study of hospice care in assisted living facilities:
Therefore, a hospice stands to gain financially if it provides minimal services to a beneficiary over a long period of time.
Medicare keeps paying for the days while the patient gets minimal care.
The study found longer hospice care and higher Medicare payments for beneficiaries in assisted living than for those in other settings. It recommended targeting reviews toward hospices with concentrations of long stays, particular diagnoses, assisted-living payments or patients who rarely received visits.
The Social Security Act includes a medical-review provision for long stays.
The clinical question remains whether the patient’s condition supports the prognosis at the relevant certification. A physician’s narrative should explain that judgment through the individual’s circumstances. For an insider, the revealing comparison is the clinical account against the direction to admit, retain or discharge that patient.
A patient can continue receiving hospice care when the required recertifications support eligibility. Medicare permits two 90-day benefit periods followed by unlimited 60-day periods, with a new certification for each period. Continued coverage rests on the renewed clinical judgment about the patient’s condition.
That makes the recertification file central to long-stay review. It records what the hospice said about the patient when it sought to keep Medicare paying.
Internal reviews can show that a hospice knew about unsupported certifications before an outside reviewer asked for records. Complaints involving Evercare, Homestead and Heartland describe different ways that knowledge allegedly reached the people controlling the business.
Whistleblowers brought the Evercare case, and the government joined it. In its complaint against Evercare, the government alleged that internal audits at several locations found documentation that did not support initial certifications or recertifications. The point for an insider is the circulation of that finding: what the audit identified, who received it and what happened to the affected patients’ billing afterward.
At Homestead Hospice, a whistleblower complaint alleged that proposed discharges had to go through a corporate review group:
To prevent ineligible patients from being discharged, Homestead Hospice requires that each patient determined to be inappropriate for hospice and proposed for discharge by field clinicians be routed to the corporate “Medical Review Group” to make for the ultimate decision on the patient’s eligibility.
The alleged review process put a corporate decision between the clinician’s recommendation and the patient’s discharge. The field assessment and the corporate response would tell different parts of that story. A medical-review department can have the information needed to end an unsupported stay while management controls whether that happens.
The whistleblower complaint against Heartland Hospice alleged a more calculated response to Medicare’s requests. It said Heartland withheld records because accepting denial of one monthly claim could keep reviewers from seeing the same patient’s alleged ineligibility in earlier months. Accepting one denial allegedly helped keep earlier payments out of view. The complaint also alleged an instruction to add an unsupported advanced-cancer diagnosis to a record requested for review.
The same complaint alleged that Heartland restricted reviews of discharged patients to the final month, avoiding an examination of earlier payments that might need to be refunded. The original chart, the response packet and the instructions about what to examine would expose different pieces of the alleged conduct.
Evidence of health care fraud connects the patient, the billed care, the inaccurate record or claim, and the people who knew about the discrepancy. A review finding gains force when it can be connected to an instruction, a changed record or continued billing for the affected patient.
A nurse may know what the assessment showed before someone changed it. A medical director may know what information reached the certification meeting. Billing and compliance employees may know which claims continued after an internal audit. Those perspectives let hospice whistleblowers explain a decision that the submitted packet alone may conceal.
A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.
If you saw a chart rewritten for an ADR, an audit finding buried or billing continue after a clinical objection, speak with our whistleblower experts about the review and the response. We help build your case around the patient records, the payments and the people directing those decisions. We bring in hospice fraud whistleblower lawyers who understand medical-review disputes and stay beside you throughout the case.